Journal Article Summary
The article investigates the effectiveness of long-acting progestogens compared to the combined oral contraceptive pill (COCP) in preventing the recurrence of pain related to endometriosis after surgical treatment. Endometriosis is a common condition affecting many women of reproductive age, characterized by the growth of tissue similar to the lining of the uterus outside the uterus, leading to significant pain and potential fertility issues. Understanding which hormonal treatment is more effective in managing pain recurrence is crucial for improving the quality of life for women undergoing surgery for this condition.
In the study, 405 women aged 16 to 45 who were undergoing surgery for endometriosis were randomly assigned to receive either long-acting progestogens (such as depot medroxyprogesterone acetate or a levonorgestrel-releasing intrauterine system) or the COCP. The primary outcome measured was pain levels assessed three years after treatment using a specific questionnaire. Results showed that both treatment options led to a similar reduction in pain, with approximately a 40% improvement from preoperative levels. However, women receiving long-acting progestogens experienced fewer instances of needing additional surgeries or treatments compared to those on the COCP.
While the study provides valuable insights, it has limitations, including a predominance of white participants, which may affect the generalizability of the findings to other ethnic groups. Additionally, many participants switched treatments during the study, which could influence the results. Patients should discuss these findings with their healthcare providers to understand the best treatment options for their individual situations, especially considering the potential for reduced need for further surgeries with long-acting progestogens.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Cooper Kevin G, Bhattacharya Siladitya, Daniels Jane P, Horne Andrew W, Clark T Justin, Saridogan Ertan, Cheed Versha, Pirie Danielle, et al.. Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain: the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial. The BMJ 2024. DOI: 10.1136/bmj-2023-079006. PMID: 38749550. PMCID: PMC11094611.
Featured Pill Pals Product
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) --- Perrigo --- Over The Counter
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) — Perrigo — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
